Aadi bioscience to report second quarter 2023 results and operational update

Company to host conference call and webcast on wednesday, august 9, 2023 los angeles , aug. 2, 2023 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mtor pathway genes, today announced that it will host a conference call and live webcast on wednesday, august 9, 2023 at 8:30 am et (5:30 am pt) to report second quarter 2023 financial results and provide an operational update. conference call information  participants may access a live webcast of the call on the "investors & news" page of the aadi bioscience website at www.aadibio.com.
AADI Ratings Summary
AADI Quant Ranking